Viewing Study NCT00623805


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-01-04 @ 5:52 PM
Study NCT ID: NCT00623805
Status: COMPLETED
Last Update Posted: 2014-08-08
First Post: 2008-02-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Sponsor: Hoffmann-La Roche
Organization: